56 results
Page 2 of 3
8-K
EX-2.1
ksn8n
1 Apr 21
Entry into a Material Definitive Agreement
8:10am
8-K/A
EX-1.1
xgq2zo681x1j4znipum6
21 Jun 19
Entry into a Material Definitive Agreement
5:10pm
424B5
ftp5s1pn2mmo7cu
20 Jun 19
Prospectus supplement for primary offering
4:11pm
8-K
EX-1.1
hmcb 3opg2f6ql2
20 Jun 19
Eloxx Pharmaceuticals Announces Proposed
4:05pm
424B5
r0uwqy89w78ygwdn5
19 Jun 19
Prospectus supplement for primary offering
4:02pm
8-K
EX-99.1
oesf2a6q1 o0ug72
9 May 19
Eloxx Pharmaceuticals Reports First Quarter 2019 Financial and Operating Results and Provides Business Update
8:00am
8-K
EX-99.1
z9kl u051kd6jke
8 Mar 19
Eloxx Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial and Operating Results and Provides Business Update
7:33am
8-K
EX-10.1
j9mif
16 Nov 18
Entry into a Material Definitive Agreement
4:11pm
8-K
EX-1.1
ums qmmj9nshaiw
26 Apr 18
Eloxx Pharmaceuticals Announces Proposed
5:09pm